Access keys

Skip to content Accessibility Home News, events and publications Site map Search Privacy policy Help Contact us Terms of use

Impact award finalists announced

BBSRC has announced the finalists in its 2013 Activating Impact and Innovator of the Year competitions.

All competitors will find out who has won the prestigious titles at a final in central London on 20 March 2013.

The two competitions form part of BBSRC's Fostering Innovation programme, which also includes the Excellence with Impact awards, celebrating the success of scientists, knowledge exchange practitioners and institutions which have translated excellent research into social and economic benefits.

Activating Impact is a new competition which has been created to celebrate the work of successful Knowledge Exchange and Commercialisation (KEC) teams or individuals that make essential contributions in turning excellent bioscience research supported by BBSRC into real-life applications.

As well as recognising these contributions the competition aims to promote best practice in KEC amongst the bioscience community and stimulate innovative approaches to future KEC activities in the biosciences.

The winning team will receive £50,000 andup to two runner-ups will receive £25,000 to contribute to an aspect of the organisation's strategy for KEC.

Activating Impact 2013 finalists

  • University of Aberdeen (University of Aberdeen Research and Innovation)
  • University of Cambridge (Cambridge Enterprise Ltd, University of Cambridge)
  • The University of Edinburgh and The Roslin Institute (Edinburgh Research and Innovation Ltd.)
  • The University of Manchester (The University of Manchester Intellectual Property (UMIP), a division of UMI3 Ltd)
  • The University of Nottingham (University of Nottingham Technology Transfer Office)
  • University of Oxford (Research Services, University of Oxford)

Innovator of the Year is an established competition recognising the efforts of BBSRC-funded scientists to take their work beyond the lab and deliver social and economic advantages.

The Innovator of the Year finalists compete in one of the three categories; 'Commercial Innovator', 'Social Innovator' and 'Most Promising Innovator' which reflect the breadth of the benefits delivered by BBSRC's investment in UK bioscience. One of the category winners will be chosen as the overall Innovator of the Year by the independent panel of expert judges.

Winners in each category will receive a £10,000 award to support research, training or other activities promoting economic or social impact. The overall winner will receive a further £5,000 and their department will receive £15,000.

Previous winners include the University of Cambridge's Professor Shankar Balasubramanian, who co-invented Solexa Sequencing, an ultrafast way to sequence DNA. The firm he co-created, Solexa, was sold for $600M.

In 2012 Professor George Lomonossoff of the John Innes Centre won the overall title for his work developing a safe and accessible way to manufacture proteins in plants, which could revolutionise vaccine screening.

Innovator of the Year 2013 finalists

Commercial Innovator

  • Stefan Przyborski, University of Durham – Technology that enhances the value and relevance of cell-based assays for discovery and screening applications
  • Hagan Bayley, University of Oxford – Engineered protein nanopores
  • Anna Hine, Aston University – Advancement of protein engineering for global biotechnology/pharma

Social Innovator

  • Ian Graham, University of York – High value chemicals from plants: molecular breeding of pharmaceutical crops
  • Peter Mertens and Simon Carpenter, Simon Gubbins and Carrie Batten, The Pirbright Institute – Identification, modelling and control of bluetongue outbreaks in the UK and northern Europe

Most Promising Innovator

  • Ryan Donnelly, Queen's University Belfast – Hydrogel-forming microneedle arrays for enhanced drug delivery and patient monitoring
  • Tim Dafforn and Mathew Hicks, University of Birmingham – A synthetic biology solution to pathogen detection



BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.

Funded by Government, and with an annual budget of around £500M (2012-2013), we support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.

For more information about BBSRC, our science and our impact see:
For more information about BBSRC strategically funded institutes see:

Tags: commercialisation innovation people BBSRC press release